NID1, a new regulator of EMT required for metastasis and chemoresistance of ovarian cancer cells
Open Access
- 13 March 2017
- journal article
- research article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (20), 33110-33121
- https://doi.org/10.18632/oncotarget.16145
Abstract
NID1, a new regulator of EMT required for metastasis and chemoresistance of ovarian cancer cells NID1, a new regulator of EMT required for metastasis and chemoresistance of ovarian cancer cellsKeywords
This publication has 40 references indexed in Scilit:
- Identification of the IGF1/PI3K/NF κB/ERK gene signalling networks associated with chemotherapy resistance and treatment response in high-grade serous epithelial ovarian cancerBMC Cancer, 2013
- Prognostically relevant gene signatures of high-grade serous ovarian carcinomaJournal of Clinical Investigation, 2012
- Akt/PKB-Mediated Phosphorylation of Twist1 Promotes Tumor Metastasis via Mediating Cross-Talk between PI3K/Akt and TGF-β Signaling AxesCancer Discovery, 2012
- Epithelial–Mesenchymal Transition in Ovarian CarcinomaFrontiers in Oncology, 2012
- Integrated genomic analyses of ovarian carcinomaNature, 2011
- Phosphorylation of Serine 68 of Twist1 by MAPKs Stabilizes Twist1 Protein and Promotes Breast Cancer Cell InvasivenessCancer Research, 2011
- Basement Membranes: Cell Scaffoldings and Signaling PlatformsCold Spring Harbor Perspectives in Biology, 2010
- Basement membrane components are key players in specialized extracellular matricesCellular and Molecular Life Sciences, 2010
- Impaired wound healing in mice lacking the basement membrane protein nidogen 1Matrix Biology, 2010
- A Gene Signature Predicting for Survival in Suboptimally Debulked Patients with Ovarian CancerCancer Research, 2008